Trade Summary

1 week ago, Lee Sung, serving as EVP, Chief Financial Officer at CYTOKINETICS INC (CYTK), sold 38,730 shares at $82.30 per share, for a total transaction value of $3,187,479.00. Following this transaction, Lee Sung now holds 63,221 shares of CYTK.

This sale represents a 37.99% decrease in Lee Sung's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, June 24, 2026 and publicly disclosed via SEC Form 4 filing on Monday, June 29, 2026 at 6:05 PM ET, 5 days after the trade was made.

CYTOKINETICS INC operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.